AE 002
Alternative Names: AE-002Latest Information Update: 25 Mar 2021
At a glance
- Originator ActualEyes
- Class Eye disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Fuchs' endothelial dystrophy